János Szebeni, MD, PhD, DSc
Executive and Science Officer
János Szebeni, M.D., Ph.D., D.Sc., Med. Habil., immunologist, founder and CEO of a contract research SME “SeroScience”. He is also director of the Nanomedicine Research and Education Center at Semmelweis University, Hungary and full professor of (immune) biology at Miskolc University. He has held various guest professor and scientific positions in Hungary and abroad, mostly in the USA where he lived for 22 years. His research on various themes in hematology, membrane biology and immunology resulted >150 publications including peer-reviewed papers, book chapters, patents, etc. (citations: >6230, H index: 41, i10 index: 77), and a book entitled “The Complement System: Novel Roles in Health and Disease” (Kluwer, 2004). He was PI in >10 European and Hungarian grants and >30 CRO projects over the past 10 years; international conference or seminar speaker >60 times over the past 5 years, and ad hoc consultant for the FDA. Three fields stand out where he has been most active: artificial blood, liposomes and the complement system. His original works led to the “CARPA” concept, i.e., that complement activation underlies numerous drug-induced (pseudo)allergic (infusion) reactions. CARPA has been included in a recent EMA guideline as a recommended preclinical safety test.
Márton Jani, MSc
Mr Jani has background in biology and chemistry and has held senior scientist and R&D group leader positions in the preclinical CRO field before joining SeroScience in early 2016. Mr Jani serves as operations officer since late 2016.
Péter Krajcsi, PhD, DSc
Business Development Manager
Dr. Krajcsi is a scientist and manager with extensive experience in biotechnology. In his academic career he has focused on four major topics (i) steroid receptors (ii) molecular biology of adenoviruses (iii) apoptosis and (iv) membrane transport. For the past two decades he has been working in R&D management positions for small and medium size enterprises in drug research and gene therapy in Hungary and the United States.